On June 4, 2025, Sundy Biotechnology (Suzhou) Co., Ltd. (hereinafter referred to as "Sundy Bio") and Guangzhou Genesail Biotechnology Co., Ltd. (hereinafter referred to as "Genesail Bio") officially signed a strategic cooperation agreement today. Based on their respective deep accumulations in lipid nanoparticle (LNP) delivery technology and circRNA in vitro synthesis stock solution field, the two parties will achieve complementary advantages and resource sharing, jointly promote the development of circRNA-LNP therapy, the ad...
-
- 2025-03-27
- Scindy Pharmaceutical invites you to attend the 6th bionnova biomedical innovators' Forum and exhibition and meet with Zhangjiang Science Hall in Shangha...
- Scindy Pharmaceutical (Suzhou) Co., Ltd. is a high-tech enterprise with independent innovation of nano carriers as the core. It is committed to promoting the basic research and clinical transfor...
-
- 2024-11-27
- Scindy Pharmaceutical: Advanced delivery technology accelerates the development of innovative therapies such as RNA...
- Scindy Biopharmaceutical (Suzhou) Co., Ltd. is a research and development platform enterprise with independent innovation of nanocarriers as its core....
-
- 2024-08-08
- Scindy Pharmaceutical with Yanyin Technology to expand into new fields of synthetic biology...
- Recently, Scindy Pharmaceutical (Suzhou) Co., Ltd. (hereinafter referred to as "Scindy Pharmaceutical") and Shanghai Yanyin Technology Co., Ltd. (hereinafter referred to as "Yanyin Tech...
-
- 2023-12-05
- Scindy Pharmaceutical and Levostar Forge Strategic Partnership in “mRNA-LNP” Field...
- On November 30, 2023, Scindy Pharmaceuticals (Suzhou) Co., Ltd. (hereinafter referred to as “Scindy Pharmaceutical”) and Levostar Life Sciences (Suzhou) Co., Ltd. (hereinafter referre...
-
- 2023-11-15
- Scindy Pharmaceutical has entered into a strategic partnership with GenePharma
- On November 14, 2023, Scindy Pharmaceutical (Suzhou) Co., LTD. (hereinafter referred to as "Scindy Pharmaceutical") announced a strategic cooperation with Suzhou Gene Pharma Co., LTD...
-
- 2023-09-25
- Our three NeoLNP™ transfection kits have just hit the market!
- LNP, represented by non-viral vectors, serves not only as a vital tool in life sciences for gene-related research but also as the cornerstone technology for innovative therapies such as RNA ther...
-
- 2023-09-27
- The 8th China Pharmaceutical Innovation and Investment Conference was held in Suzhou...
- On the 25th of May, the 8th China Medical Innovation and Investment Conference was held in Suzhou Industrial Park. He Wei, Vice Chairman of the 14th National People's Congress Standi...
-
- 2023-09-18
- Shanghai Municipal Science and Technology Commission and others on the issuance of the Action Plan for Promoting Gene Therapy Scientific and Technol...
- Notice on issuing Shanghai Action Plan for Promoting Scientific and Technological Innovation and Industrial Development of Gene Therapy (2023-2025)...
-
- 2023-08-25
- Li Qiang presided over the executive meeting of The State Council to review and adopt the Action Plan for High-quality Development of the Pharmaceutic...
- Beijing, Aug. 25, Xinhua News Agency On August 25, Premier Li Qiang presided over an executive meeting of The State Council to review and adopt the Action Plan for High-quality Develo...
